Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0001610717-23-000294 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-20 | 2023-09-18 | RVMD | GOLDSMITH MARK A | See Remarks, Dir | S - Sale | $31.31 | -8,054 | 349.3K | -2% | -$252.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-18 | S | D | 8,054 | $31.31 | 349,332 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $31.0915 to $31.3108. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F3) Includes 174,000 RSUs. |